Fevertree Drinks PLC (FEVR.L)
GBp 785.0
(0.13%)
GBp 785.0
(0.13%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -1.9 Million | 8.5 Million | 46.8 Million | 38.1 Million | 68 Million | 45.64 Million |
| Net Income | 15.4 Million | 31 Million | 55.6 Million | 51.6 Million | 72.5 Million | 75.57 Million |
| Depreciation & Amortization | 8 Million | 5.8 Million | 4.7 Million | 3.8 Million | 2.9 Million | 1.45 Million |
| Deferred income taxes | - | - | - | -16.5 Million | -12 Million | -12.74 Million |
| Stock-based compensation | 1.7 Million | 3.3 Million | 2.7 Million | 1.9 Million | 1.9 Million | 1.82 Million |
| Change in working capital | -29.6 Million | -22.2 Million | -9.2 Million | -2.4 Million | 3 Million | -20.25 Million |
| Other non-cash items | 47.8 Million | -9.4 Million | -7 Million | -300 Thousand | -300 Thousand | -220.2 Thousand |
| Investing Cash Flow | -9.6 Million | -10 Million | -4.3 Million | -3.8 Million | -2.1 Million | -1.15 Million |
| Investments in PPE | -9.6 Million | -7.1 Million | -4.6 Million | -2.6 Million | -2.6 Million | -1.47 Million |
| Acquisitions | - | -3.7 Million | - | -1.7 Million | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -5 Million | 800 Thousand | 300 Thousand | 500 Thousand | 500 Thousand | 327.2 Thousand |
| Financing Cash Flow | -23.1 Million | -70.7 Million | -19.3 Million | -19.6 Million | -27 Million | -12.75 Million |
| Debt repayment | - | - | -100 Thousand | -900 Thousand | -6.1 Million | - |
| Dividends payments | -19.1 Million | -68.8 Million | -18.4 Million | -17.8 Million | -18 Million | -13.72 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | 1.08 Million |
| Other Financing Activities | -4 Million | -1.9 Million | -800 Thousand | -900 Thousand | -2.9 Million | -107 Thousand |
| Accounts receivables | -22.3 Million | -1.6 Million | -14.6 Million | 4 Million | 1.3 Million | -7.3 Million |
| Accounts payables | 4.8 Million | 500 Thousand | 7.7 Million | 10.8 Million | -4 Million | 3.46 Million |
| Inventory | -10 Million | -23.5 Million | 500 Thousand | -17.2 Million | 5.7 Million | -16.41 Million |
| Other working capital | -2.1 Million | 2.4 Million | -2.8 Million | - | - | - |
| Cash at beginning of period | 95.3 Million | 166.2 Million | 143.1 Million | 128.3 Million | 89.7 Million | 56.95 Million |
| Cash at end of period | 59.9 Million | 95.3 Million | 166.2 Million | 143.1 Million | 128.3 Million | 89.72 Million |
| Capital Expenditure | -9.6 Million | -7.1 Million | -4.6 Million | -2.6 Million | -2.6 Million | -1.47 Million |
| Effect of forex changes on cash | -800 Thousand | 1.3 Million | -100 Thousand | 100 Thousand | -300 Thousand | 1.02 Million |
| Net cash flow / Change in cash | -35.4 Million | -70.9 Million | 23.1 Million | 14.8 Million | 38.6 Million | 32.76 Million |
| Free Cash Flow | -11.5 Million | 1.4 Million | 42.2 Million | 35.5 Million | 65.4 Million | 44.16 Million |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 7.6 Million | 14.3 Million | 15.4 Million | 1.1 Million | 31 Million | 10.8 Million |
| Depreciation & Amortization | 4.2 Million | 3.9 Million | 8 Million | 4.09 Million | 5.8 Million | 3.4 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | 1.7 Million | - | 3.3 Million | - |
| Change in working capital | 5.7 Million | -10.3 Million | -29.6 Million | -19.3 Million | -22.2 Million | -1.6 Million |
| Other non-cash items | 8 Million | 14.1 Million | 47.8 Million | 33.7 Million | -9.4 Million | 8 Million |
| Investing Cash Flow | -5.1 Million | -6.7 Million | -9.6 Million | -2.9 Million | -10 Million | -8.5 Million |
| Investments in PPE | -2.1 Million | -6.7 Million | -9.6 Million | -2.9 Million | -7.1 Million | -4.8 Million |
| Acquisitions | - | - | - | - | -3.7 Million | -3.7 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | 800 Thousand | - |
| Financing Cash Flow | -14.6 Million | -9 Million | -23.1 Million | -14.1 Million | -70.7 Million | -8 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | -12.7 Million | -6.7 Million | -19.1 Million | -12.4 Million | -68.8 Million | -6.6 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -1.9 Million | -2.3 Million | -4 Million | -1.7 Million | -1.9 Million | -1.4 Million |
| Accounts receivables | 12.1 Million | -19.9 Million | -22.3 Million | -2.4 Million | -1.6 Million | 8.6 Million |
| Accounts payables | -14.2 Million | -6.9 Million | 4.8 Million | 11.7 Million | 500 Thousand | -5.5 Million |
| Inventory | 6.4 Million | 15.9 Million | -10 Million | -25.9 Million | -23.5 Million | -3.9 Million |
| Other working capital | 1.4 Million | 600 Thousand | -2.1 Million | -2.7 Million | 2.4 Million | -800 Thousand |
| Cash at beginning of period | 59.9 Million | 75.8 Million | 95.3 Million | 95.3 Million | 166.2 Million | 100 Million |
| Cash at end of period | 65.9 Million | 59.9 Million | 59.9 Million | 75.8 Million | 95.3 Million | 95.3 Million |
| Capital Expenditure | -2.1 Million | -6.7 Million | -9.6 Million | -2.9 Million | -7.1 Million | -4.8 Million |
| Effect of forex changes on cash | - | -3.5 Million | -800 Thousand | 2.7 Million | 1.3 Million | -1.2 Million |
| Net cash flow / Change in cash | 6 Million | -15.9 Million | -35.4 Million | -19.5 Million | -70.9 Million | -4.7 Million |
| Free Cash Flow | 23.4 Million | -3.4 Million | -11.5 Million | -8.1 Million | 1.4 Million | 8.2 Million |
SURFI
JAL
MEDICAMEQ
NDGPF
VBX
8159